Intranasal siRNA nanoparticles targeting c-kit reduced infiltration of eosinophils in BAL fluid, downregulated the production of SCF, IL-4, and IL-5, and suppressed airway mucus secretion in an OVA-induced mouse asthma model [95]. Here, IL4 is linked to asthma.